hyp

Showing 1 posts of 1 posts found.

New 2-in-1 Valturna outperforms Diovan

October 1, 2009
Sales and Marketing Diovan, Novartis, Tekturna, cv, hyp, hypertension

Novartis has gained US approval for a combination of its blockbuster blood pressure drug Diovan and its follow-up product Tekturna/Rasilez.Valturna …

The Gateway to Local Adoption Series

Latest content